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Abstract 
Here we report the use of peptide engineering to develop self-assembling membranes that are 
responsive to cellular activities, in particular to hydrolytic degradation by specific enzymes. The 
membranes are obtained by combining the matrix polymer hyaluronan (HA) and a rationally 
designed peptide amphiphile (PA) containing a proteolytic domain (GPQGIWGQ octapeptide) 
sensitive to matrix metalloproteinase-1 (MMP-1). The self-assembly behavior of the designed 
MMP-1 sensitive PA was studied by circular dichroism (CD) spectroscopy, transmission electron 
microscopy (TEM) and ability to form membranes with HA. We found that the insertion of an 
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octapeptide in a typical PA structure does not disturb its self-assembly process into fibrillar 
nanostructures. CD shows the formation of -sheet secondary structures in a broad pH range and 
TEM reveals the presence of filamentous nanostructures. In the presence of high molecular weight 
HA, this PA forms self-assembling membranes exhibiting a nanofibrillar morphology. Membrane 
enzymatic degradation was then investigated in vitro in presence of exogenous enzymes 
(hyaluronidase and MMP-1). Our studies reveal that membranes containing the MMP-1 substrate 
exhibit enhanced enzymatic degradation, compared with control membranes (absence of MMP-1 
cleavable peptide or containing a MMP-1 insensitive sequence), being completely degraded after 
7 days. Cell culture studies on the developed membranes, using human dermal fibroblasts (hDFbs), 
show that cell viability and proliferation is minimally affected by the enzymatically cleavable 
functionality present on the membrane. However, the presence of MMP-1 cleavable sequence 
does stimulate the secretion of MMP-1 by hDFbs and interfere with matrix deposition, particularly 
the deposition of collagen. By showing cell-responsiveness to biochemical signals presented on 
self-assembling membranes, this study highlights the ability of modulating certain cellular 
activities through matrix engineering. We believe this concept can be further explored to 
understand the cellular remodeling process in different tissues and could also be used as a 
strategy to develop artificial matrices with more biomimetic degradation for tissue engineering 
applications. 
 
Keywords: peptide amphiphiles; hyaluronan; self-assembling membranes; matrix 
metalloproteinase-1; degradation; enzyme-responsive materials  
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1. Introduction  
The specific and selective activities of enzymes, together with their ability to be controlled by 
environmental conditions, such as pH, temperature and ionic strength, have been extensively 
explored in the materials science community with the aim of producing materials with customized  
functionalities while offering the possibility to perform catalysis reactions very efficiently in mild 
conditions. According to a recent review published by Ulijn and co-workers on enzyme responsive 
materials (ERMs),[1] they define ERMs as materials that change their functionality as a result of the 
direct action of an enzyme on the material. The ubiquitous distribution and great diversity of 
enzymes present in the human body has motivated biomedical engineers to design biomaterials 
responsive to enzyme activities and thus translate the enzymatic modification into a suitable 
materials response. Because the trigger is provided by the biological environment (e.g. cells), with 
no need to be added exogenously, ERMs offer additional advantages for biomedical applications 
when compared with other stimuli-responsive (e.g. light, temperature) materials. Enzymes can 
either be used to form new covalent bonds (e.g. isopeptide bonds between side groups of amino 
acids in peptides and proteins by transglutaminase, leading to the cross-linking and strengthening 
of the material), or the cleavage of pre-existing bonds (e.g. hydrolysis of peptide bonds by 
proteases, leading to the material degradation or disassembly). In the context of 3D biomaterials 
for cell culture, enzymes have been mainly used to form polymer hydrogels, by incorporating 
enzyme sensitive cross-links and thus induce gelation in vivo, or, conversely, to mimic the 
degradation process during tissue remodeling and favor cell migration and invasion through 
enzyme sensitive polymer hydrogels. Both approaches were pioneered by the Hubbell’s lab to 
develop polyethylene glycol (PEG)-based hydrogels with different functionalities.[2, 3] These 
concepts were then applied to other natural[4, 5] and synthetic[6] polymer hydrogels. Similarly, 
enzyme responsive supramolecular hydrogels were developed, including the formation of gels that 
are obtained by enzyme-directed self-assembly[7] (an enzyme is used to catalyze the synthesis of 
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self-assembling molecules or the removal of a block to trigger the self-assembly), and the 
degradation[8, 9, 10] of supramolecular gels by enzyme mediated disassembly (enzyme converts the 
self-assembling blocks into non-self-assembling molecules or by degrading the building block 
directly).[1] Selective enzymatic degradation was also shown to be advantageous in modulating the 
properties of self-assembled nanostructures, such as nanostructure transitions. For example, 
Webber and co-workers designed a peptide amphiphile (PA) containing a sequence that is a 
substrate of a protein kinase A (PKA).[11] Upon treatment with PKA, the PA molecules became 
phosphorylated causing the disassembly of the original cylindrical structures. Subsequent 
treatment with alkaline phosphatase enzyme, which cleaves the phosphate groups, resulted in PA 
reassembly. Seitsonen and co-workers used the model protease -chymotrypsin to control the 
morphologies of peptide self-assemblies (nanotubes/helical ribbons, spherical micelles).[12] In a 
different approach, Lin and co-workers used a specific proteinase to degrade a cross-linker that 
stabilizes supramolecular peptide filaments.[13] 
Normally during granulation tissue formation, the remodeling of the natural extracellular matrix 
(ECM) occurs simultaneously with cell invasion. The macromolecular components of the ECM are 
degraded by cell-secreted proteases, mainly by matrix metalloproteinases (MMPs). The MMPs are 
a family of protease enzymes that are able to cleave structural components of the ECM, such as 
collagen types I and IV and fibrin, playing an important role in morphogenesis, wound healing and 
tissue remodeling.[14] In general, MMPs are not continuously expressed in the skin, but are 
induced temporarily in response to exogenous signals or pathogenic conditions, such as wound 
healing.[15] In later stages of dermal wound healing, fibroblasts are the main cell population that 
produce native ECM[16] and secrete active MMPs (MMP-1, -2, -9 and -13).[15, 17] The action of MMP-
1 is essential in the remodeling stage during wound healing.[18] This enzyme is an antagonist to the 
ECM synthesis and therefore mediates the balance between tissue synthesis and degradation. 
Several attempts in biomaterial design have been made to mimic this feature of natural ECMs by 
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including protease-sensitive peptides that are cleaved in the presence of cell-secreted enzymes, 
thus providing further control over cellular responses.[2, 19]  The inclusion of MMP-sensitive 
sequences into PEG gels has been explored by Hubbell’s lab to promote cell migration within 
hydrogels.[2, 20, 21] When the gels come into contact with cells in vitro or in vivo, they were locally 
degraded as the cells respond to cues presented by the gels. The inclusion of MMP cleavable 
sequences into self-assembling peptides has been explored for different biomedical applications, 
including enzyme responsive hydrogels for controlled matrix degradation and cell migration in 
tissue engineering,[8, 9, 22] enzyme-triggered drug delivery systems[23] and sensing systems for 
detecting cell-secreted MMPs overexpressed in various diseases.[24] 
Hyaluronan (HA), a major component of the ECM, has attracted considerable interest in a wide 
range of biomaterials applications.[25] Its unique physicochemical properties[26] (high molecular 
weight and density of negative charges, inherent biodegradability and biocompatibility), 
associated with its complex interactions with ECM components and cells,[27] have led us and others 
to consider this simple polymer as building block for designing biomimetic materials. Moreover, 
HA has shown to play important roles in wound healing.[28]  
As bottom-up approach, self-assembly allows the design of biomaterials with specific 
functionalities and nanoscale organization similar to natural tissues. The formation of 
hierarchically ordered membranes by self-assembly between high molecular weight HA and 
positively charged peptide amphiphiles (PAs) was first reported in the seminal work of Stupp and 
co-workers.[29] We have then used the same approach to fabricate membranes integrating 
biochemical signals (RGDS ligand) to enhance the adhesion of fibroblasts in serum-free culture 
conditions.[30] To further expand the versatility of these self-assembling membranes as temporary 
matrices for wound healing applications, and recreate some of the aspects of matrix remodeling, 
an enzymatic cleavable peptide sequence has now been included into the peptide domain. The 
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inclusion of this sequence allows the creation of membranes that are degraded in response to cell-
secreted enzyme activities at the wound site during tissue remodeling. 
Therefore, the objective of this study was to develop self-assembling membranes made of HA and 
PAs containing a cleavable site for MMP-1. Since hyaluronidase and MMP-1 enzymes are released 
by fibroblasts during wound healing, we further examined the ability of these enzymes to degrade 
the self-assembling membranes. The biological functionality of the membranes was also 
investigated by culturing human dermal fibroblasts and their effect on cell behavior, like cell 
adhesion, proliferation and ECM synthesis, evaluated.  
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2. Results and discussion 
2.1. Design and self-assembly of PAs with enzymatic cleavable sequences 
The self-assembly of HA with positively charged peptides containing the RGDS epitope has 
previously been explored by our group to generate membranes with different densities of peptide 
ligands and thus control the adhesion of different cell types.[30, 31] To add different functionalities 
into our membrane design, such as programmed degradation, a similar molecular engineering 
approach was pursued in this work by including the matrix metalloproteinase-1 (MMP-1) cleavable 
site into the peptide building block. The peptide self-assembling blocks used in this study are 
based on the peptide amphiphile design pioneered by Stupp[32] and are composed of a 
hydrophobic segment coupled to a peptide segment, that includes a β-sheet forming sequence 
(V3A3) and a domain with positively charged amino acids (K3) to bind the anionic HA (K3 PA, Figure 
1A).[29] A MMP-1-sensitive PA was designed by incorporating the sequence GPQG↓IWGQ[2, 20, 21, 33] 
(arrow denotes the expected cleavage site by MMP-1) between the β-sheet domain and the lysine 
residues (MMPsK3 PA, MMP sensitive). This peptide is the mutated version of the sequence 
GPQG↓IAGQ found within the α chain of type I collagen of calf and chick, as well as human.[34] The 
single substitution of Ala by Trp was shown to enhance enzymatic cleavage.[2, 35] The human α1 
type IV collagen sequence, GDQGIAGF, was chosen as a negative control. This sequence has been 
described to be insensitive to MMP-1 degradation (MMPiK3 PA, MMP insensitive).
[2, 36] By inserting 
the GPQG↓IWGQ segment between the HA-binding region and the β-sheet forming segment in 
the original PA design, instead of adding it to the C-terminus, we aim to promote the breakdown 
of the peptide at a point that would facilitate the release of the HA-binding motif from the PA 
nanofibers, hindering binding to HA to remain bound. The lack of interaction between the PA 
nanofibers and the HA chains would favor the disassembly and dissolution of the membrane 
components. In addition to MMP-1, hyaluronidase (HAase) has also been implicated in tissue 
remodeling during wound healing. The presence of HAase will further contribute for the 
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membrane disassembly and degradation by hydrolyzing HA into smaller fragments.[30] We 
hypothesize that the incorporation of enzymatic cleavable building blocks in the formulation of 
our membranes, enables the complete degradation of its components by cell-secreted enzymes 
and this process would resemble the breakdown of native ECM during tissue remodeling. 
The ability of K3-PA to form β-sheet secondary structures at certain pHs and to self-assemble into 
nanofibers was shown previously.[30] However, significant modifications, like the insertion of a 
sequence containing eight amino acids, may affect the self-assembly properties of the resulting 
PAs. Profiling the secondary structure of the GPQGIWGQ-containing PA by CD spectroscopy and 
examining the existence of β-sheets can provide basic information to understand their assembling 
properties (Figure 1B). The CD spectra of β-sheet structures are typically characterized by a 
minimum at 216 nm and a maximum at 195 nm, while random coils present a maximum at 218 nm 
and a minimum at 198 nm.[37] The CD spectra obtained for K3PA at neutral and basic pH were 
consistent with the known fact that this peptide has a dominant β-sheet content.[30, 38] The 
inclusion of the sequences GPGIWGQ and GDQGIAGF between the β-sheet domain and the 
positively charged lysine residues seems to reinforce the β-sheet behavior of the peptides (Figure 
1B). A typical β-sheet signature was observed for both peptides in all the studied pH conditions, 
with a minimum in the 210-220 nm range, a crossover from positive to negative above 190 nm, 
and a positive ellipticity around 200 nm (Figure 1B). With exception of proline, all the inserted 
amino acids are either neutral or β-sheet promoters,[39] thus contributing to the formation of β-
sheet structures, independently of the solution pH. 
PAs, including these designed in this study, typically self-assemble into high-aspect-ratio 
filamentous nanostructures. TEM analysis (Figure 1C) confirmed the self-assembly of all PAs into 
nanofiber structures with diameters of between 12 and 16 nm (Table S1) and lengths of from a 
few hundred nanometers to several micrometers. Interestingly, MMPsK3 PA formed shorter 
nanofibers in comparison with K3 and MMPiK3 PAs. This might be due to the placement of a proline 
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residue next to the β-sheet forming peptide region. The cyclic structure of proline’s side chain 
confers exceptional conformation rigidity. Its unique kink formation may add some steric effect on 
the molecular packing of the adjacent residues, thus limiting the growth of the nanofiber. 
 
2.2. Membrane self-assembly 
Recent advances in biomaterials science have enabled the possibility to develop artificial matrices 
that recapitulate key features of the natural ECM critical for the process of tissue regeneration.[40]  
Based on our previous studies,[30] we hypothesize that self-assembling membranes with diverse 
functionalities can be obtained by self-assembly between HA and positively charged PAs through 
the incorporation of specific sequences recognized by cell receptors or specific enzymes (Figure 
1A). Although the insertion of a sequence of eight amino acids into the PA structure did not 
disturb their self-assembly properties (Figure 1B, 1C) the presence of this additional segment 
could potentially affect the membrane self-assembly. To prepare the membranes (Figure S4), an 
aqueous solution containing K3 PA was added on the top of the HA solution, and left to incubate 
overnight at the temperature of 37 °C. Similarly, membranes containing the MMP-sensitive (Figure 
S5) and -insensitive sequences were prepared using MMPsK3 PA  and MMPiK3 PA, respectively. 
SEM images (Figure 3B1) showed that all membranes present a nanofibrillar structure that 
resulted from the PA self-assembly in presence of the anionic polysaccharide. 
 
2.3. Membrane degradation by exogenous enzymes 
Various studies[4, 21] have showed that non-degradable hydrogels limit cellular infiltration. We have 
demonstrated that self-assembling membranes containing HA and K3 PA were susceptible to 
enzymatic degradation by HAase.[30] The incorporation of MMP-sensitive sequences in our 
membrane design is expected to promote their degradation by proteolytic enzymes and this 
would lead to enhanced cellular invasion (Figure 2). Thus, when implanted in vivo both 
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components of the membrane would be susceptible to degradation by enzymes expressed by the 
surrounding cells (e.g. HAase, MMPs) improving cell migration and tissue morphogenesis. 
To assess membrane degradability, membranes containing the MMP sensitive sequence (MMPsK3-
HA), the insensitive sequence (MMPiK3-HA) and the control (K3-HA) were incubated in PBS in the 
presence of HAase (50 U mL-1), MMP-1 (10 nM) or both enzymes. HA degradation was followed by 
quantification of a new reducing N-acetyl-D-glucosamine terminus with each cleavage reaction 
and membranes were analyzed by SEM (Figure 3). Incubation in PBS up to 14 days did not cause 
degradation of the membranes, as evidenced by the low amount of N-acetylamino sugars in the 
supernatants (Figure 3A1, A2), and the absence of evident signs of degradation in the SEM 
micrographs (Figure 3B1). When incubated in the presence of HAase, membrane degradation was 
significantly enhanced in all the conditions, which is in agreement with what we have observed 
before.[30] In the presence of MMP-1, only the MMPsK3-HA membranes showed signs of 
degradation, as seen in the SEM micrographs (Figure 3B1). From day 5, there is a slightly increase 
in the released N-acetylamino sugars (Figure 3A2). Analyzing the effect of MMP-1 activity on the 
release of N-acetylamino sugars from MMPsK3-HA and MMPiK3-HA membranes (Figure 3A3), only 
the MMPsK3-HA membranes showed an increase in the amount of N-acetylamino sugars in 
solution, while in the MMPiK3-HA the amount of N-acetylamino sugars was negligible and 
remained constant along the time. The increase in the amount of N-acetylamino sugars in solution 
might be due to the release of HA from the membrane, as the peptide being cleaved by MMP-1 (it 
breaks down the HA-binding region from the main PA sequence) weakens the interaction with HA. 
The absence of degradation in the K3-HA and MMPiK3-HA membranes in the presence of MMP-1 
suggests the specificity of the enzyme for the MMP substrate (GPQG↓IWGQ) and that the control 
sequence (GDQGIAGF) is not cleaved by the enzymatic actions of MMPs, as reported previously.[2] 
In the presence of both HAase and MMP-1, the MMPsK3-HA membranes were completely 
degraded after 14 days, demonstrating the additive effect of both enzymes. At this stage, 
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membranes underwent extensive degradation and were difficult to recover for SEM analysis, thus 
SEM micrograph shows a sample only for day 7 (Figure 3B1). SEM analysis of the cross-section of 
MMPsK3-HA membranes in the presence of MMP-1, shows that the degradation was more evident 
on the surface on the peptide side (Figure 3B2). 
 
2.4. Cell culture studies 
Effect of membrane functionalization on fibroblast proliferation 
During the early stages of wound healing, fibroblast migration and proliferation into the wound 
matrix depend on cell-matrix interactions.[18, 41] Previous work suggested that PAs bearing 
different charges could affect cell viability.[42] To investigate whether some of the sequences could 
affect fibroblast viability and proliferation, cells were cultured either on glass coverslips coated 
with different PA molecules or on membranes made with HA and the same PAs. Moreover, the 
effect of the addition of a broad-spectrum MMP inhibitor (GM6001) in cell proliferation was also 
investigated, as we intend to use this inhibitor in further experiments. DNA quantification results 
showed that cells were able to proliferate up to 7 days, either on glass coated coverslips (Figure 
S4) or on the membranes (Figure 4), which indicates that these PA molecules do not affect cell 
proliferation. Additionally, cell proliferation was greatly decreased in the presence of the MMP-
inhibitor (GM6001, 20 µM), which is consistent with what has been observed by other authors 
that suggest this inhibitor might have a reversible effect on fibroblast proliferation.[21, 43] Contrary 
to what has been observed when culturing cells in 3D hydrogels,[9, 21] there was no difference on 
cell proliferation when cells were seeded on MMPsK3-HA membranes versus MMPiK3-HA. 
 
Effect of membrane functionalization on MMP-1 secretion by fibroblasts 
In later stages of dermal wound healing, fibroblasts are the main cell population that produces 
native ECM.[16] Cells normally secrete and activate proteolytic enzymes in order to invade or 
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remodel the extracellular microenvironment.[44] In particular, primary human dermal fibroblasts 
are known to secrete active MMPs.[17] At this stage, for successful wound healing and prevention 
of fibrotic tissue, a fine balance between ECM synthesis and degradation is required. The action of 
MMP-1 is essential during the remodeling stage of wound healing.[18] Here, MMP-1 expression was 
examined at the protein level using ELISA. Fibroblasts cultured on the membranes were shown to 
secrete MMP-1. The amounts of MMP-1 released by the cells cultured on the MMPsK3-HA 
membranes were higher than those of cells cultured on the corresponding MMP-insensitive 
derivatives and on the control (K3-HA) (Figure 5A), suggesting that the presence of MMP-sensitive 
motifs in the membrane might have an influence in the secretion of MMP-1. When cultured on 
peptide coated glass coverslips, however, no differences were observed between different PAs on 
MMP-1 production (Figure S7). In addition, the values for MMPsK3-HA membranes were 2-fold 
higher than on the coated glass. These findings suggest that the mode of signal presentation to 
cells may have an influence on their response, a hypothesis that remains to be further 
investigated. Previous studies have shown the influence of matrices presenting bioactive ligands 
on the secretion of proteases.[2, 4] As expected, small amount of MMP-1 was detected in the 
supernatant in the presence of the MMP-inhibitor (Figure 5A). Confocal microscopy images 
showed elongated cells with typical fibroblast morphology (Figure 5B). After 24 h, MMP-1 was 
expressed by the cells in all the conditions but seems more evident for MMPsK3-HA membranes, 
which corroborates the ELISA results (Figure 5A). 
 
Production of ECM proteins by fibroblasts cultured on the membranes with different 
functionalities 
The native ECM of the dermis mainly consists of collagens, proteoglycans and adhesive 
glycoproteins.[45] In wound healing, fibroblasts are essential for the production of new native 
ECM.[46] To investigate the ability of hDFbs to synthesize native ECM, we determined the amount 
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of collagen and non-collagenous extracellular matrix proteins produced by the cells when cultured 
on the different membranes (Figure 6). Except for the MMPsK3-HA membranes, there was an 
increase in collagen and non-collagenous proteins production with culture time in all the 
conditions. The amount of collagen deposited on MMPsK3-HA membranes decreased with time 
(Figure 6A) while the amount of non-collagenous proteins increased, as observed for the other 
conditions (Figure 6B). The ECM turnover is controlled by the synthetic rate of matrix proteins, 
including collagenous and non- collagenous proteins, and their enzymatic degradation by MMPs. 
In particular, MMP-1 is the only protease able to unwind collagen type I and initiate its 
degradation.[47] Elevated MMP-1 activity is responsible for an increased turnover of the 
extracellular collagen matrix.[48] Taken together, the data of collagen and MMP-1 production, 
suggest that the reduced levels of collagen on MMPsK3-HA membranes (Figure 6A) could be due to 
the increased amounts of secreted MMP-1 (Figure 5A) observed for these membranes. As 
previously observed for the production of MMP-1, no differences were shown between conditions 
on the production of collagen when cells were cultured on peptide coated glass coverslips (Figure 
S8A), suggesting again the effect of matrix microarchitecture and signal presentation on cell 
behavior. 
 
Membrane microstructure after cell culture 
SEM analysis of the membranes after culturing hDFbs showed that cells were able to adhere to 
and invade the membranes (Figure 7). After 14 days of culture, the microstructure of the MMP-
sensitive membranes showed a loose network of nanofibers, when compared with the control 
membranes (K3 and MMPinsensitive). Conversely, when adding the MMP inhibitor into the culture 
medium, the membrane retained its initial morphology. These results suggest that the underlying 
membrane is responsive to the enzymatic activities produced by the cells. However, the 
membranes remained intact after 14 days, implying that cell-triggered proteolysis was localized on 
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the surface of the membranes into the cell periphery. The localization of the enzymatic 
degradation on the surface mimics proteolysis in vivo, in which ECM degradation is confined to the 
immediate pericellular environment.[44] An adequate correlation between the membrane 
degradation and production of MMP-1 is not possible at this point, because other MMPs are 
secreted by fibroblasts (MMP-2, MMP-13). In addition, a balance between active MMPs and their 
natural inhibitors (tissue inhibitors of metalloproteinases, TIMPs) could also be responsible for the 
localized degradation behavior in the membranes. Thus, we cannot conclude at the moment 
which particular molecules are involved in cell proteolysis, but we have an indication that at least 
MMP-1 is involved. 
The balanced regulation of fibroblast proliferation and ECM remodeling is essential for optimal 
wound healing results. Our in vitro data suggest that cells responded to the functionalized 
membranes, and were able to produce ECM proteins without extensive matrix deposition. The 
inclusion of a MMP-sensitive sequence into the membranes increased matrix proteolytic 
degradability, which would lead to enhanced cellular invasion when implanted in vivo, and thus 
could be beneficial for an enhanced wound healing response. The mechanisms underlying these 
observations remain, however, unclear and are worthy to be further investigated.  
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3. Conclusions 
Using a molecular engineering approach, we designed a peptide amphiphile capable of self-
assembling with hyaluronan into membranes and containing a proteolytic domain sensitive to 
matrix metalloproteinase-1 (MMP-1). By pursuing this design, we were able to modulate the 
degradation rate of the formed self-assembling membranes, as well as certain cellular responses. 
The membranes were shown to be responsive to enzymes activities, in particular to hyaluronidase 
and MMP-1, and were completely degraded after 7 days in presence of exogenous enzymes. 
Fibroblasts, very active cells in the wound healing process, were used to assess cell-mediated 
degradation of the membranes and were shown to produce higher amounts of MMP-1 when 
cultured on MMP-sensitive membranes than when cultured on the MMP-insensitive and on the 
control (bare membranes without MMP signal). These findings suggest that membranes 
containing the MMP-1 cleavable sequence stimulate protease secretion, thus leading to cell-
mediated degradation process. This hypothesis, however, needs to be further investigated. We 
expect that by including components sensitive to enzymatic activities in the membrane 
formulation, their degradation behavior may resemble the process of ECM remodeling, leading to 
increased cellular infiltration and ultimately more robust healing in vivo. Nevertheless, in vivo 
experiments will still be required to verify that the expected remodeling of the ECM actually takes 
place. These cell-interactive membranes can be further functionalized with other biochemical 
moieties to study cellular processes in vitro and also as temporary matrices in tissue engineering 
applications. 
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4. Experimental Section 
Hyaluronan (HA)  
Hyaluronan, with an average molar mass of 1.5 MDa (Lifecore Biomedical, Inc, Chaska, USA) was 
used in this study for self-assembly with the newly designed peptide amphiphiles. 
 
Peptide amphiphiles: design/structure, synthesis and purification 
Three different peptide amphiphiles (PAs) were synthesized in this work, all consisting of a peptide 
segment covalently linked to a 16-carbon alkyl chain: C15H31CO-V3A3K3 (K3 PA), C15H31CO-
V3A3GPQGIWGQK3 (MMPsK3 PA) and C15H31CO-V3A3GDQGIAGFK3 (MMPiK3 PA) (Figure 1A). The 
peptides were synthesized on a CS Bio 136XT automated peptide synthesizer (CS Bio, USA) using 
standard 9-fluorenylmethoxycarbonyl (Fmoc) based solid phase chemistry on a 4-
methylbenzhydrylamine (MBHA) rink amide resin. Amino acid couplings were performed using 4 
equivalents (4 mmol) of Fmoc protected amino acids (Novabiochem, USA), 4 equivalents of O-
(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU, Carbosynth, UK) 
and 6 equivalents of N,N-diisopropylethylamine (DIEA, Sigma, USA). Fmoc deprotections were 
performed with 20% piperidine (Sigma, USA) in dimethylformamide. A palmitic acid (C16H32O2, 
Calbiochem, USA) tail was manually coupled under the same conditions as the Fmoc-amino acids. 
Peptide cleavage from the resin, and removal of the protecting groups, was carried out on a 
mixture of trifluoroacetic acid (TFA, Sigma, USA)/triisopropylsilane (TIS, Alfa Aesar)/water 
(95/2.5/2.5)) for 3 h at room temperature. The peptide mixture was collected and excess of TFA 
was removed by rotary evaporation. The resulting viscous peptide solution was triturated with 
cold diethyl ether and the white precipitate was collected by filtration, washed with cold ether, 
and allowed to dry under vacuum overnight. The peptide mass was confirmed by electrospray 
ionization mass spectrometry (ESI-MS, Agilent, USA). 
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Peptides were then purified on a Waters 2545 Binary Gradient high-performance liquid 
chromatography (HPLC) system using a preparative reverse-phase C18 column (Atlantis Prep OBD 
T3 Column, Waters, USA) and a water/acetonitrile (0.1% TFA) gradient. TFA counter-ions were 
exchanged by sublimation from 0.01 M hydrochloric acid. Finally, the peptides were dialyzed 
against ultrapure water using 500 MWCO dialysis tubing (Spectrum labs, The Netherlands), 
lyophilized and stored at -20 °C until further use. Confirmation of mass and purity was done by ESI-
MS and HPLC (Supplementary Information, Figure S1-S3). 
 
Peptide amphiphiles characterization 
Circular dichroism (CD) spectroscopy  
Peptides were dissolved in deionized water to a final concentration of 0.011 mM and the pH was 
adjusted to 3, 7 and 9 with hydrochloric acid (0.1 M) or ammonium hydroxide (0.1 M). The CD 
measurements were performed in a PiStar-180 spectrometer from Applied Photophysics (Surrey, 
UK), under a constant flow of nitrogen (8 L.min-1) at a constant pressure value of 0.7 MPa. Far-UV 
spectra were recorded at 25 °C from 190 to 300 nm in a quartz cuvette with 1 mm path-length. All 
scans were performed in the steady state with a bandwidth of 1 nm and each represented 
spectrum is an average of 5 spectra. The molar ellipticity [θ] was calculated using equation (1). 
[ ]  
 
   
 (1) 
were θ is the measured ellipticity in mdeg, c is the concentration of the peptide in dmol L-1 and l is 
the light path length of the cuvette in cm. 
 
Transmission electron microscopy (TEM) 
Peptides were dissolved in ultrapure water (0.1 wt%) and the solution was aged for 2 days before 
TEM analysis. Peptide solutions were loaded on carbon-coated copper TEM grid (Electron 
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Microscopy Sciences, USA). For negative staining, a drop of 2 wt% uranyl acetate (Electron 
Microscopy Sciences, USA) aqueous solution was placed on the samples. The excess solution was 
wiped away by a piece of filter paper, and the sample was allowed to dry under ambient 
conditions. All images were collected with a Tecnai 12 TWIN, equipped with SIS Megaview III 
camera (FEI, USA). 
 
Preparation of self-assembled PA-HA membranes containing different functionalities 
Self-assembled membranes were prepared by combining HA with positively charged PAs at 
optimized conditions, as previously reported.[30] Briefly, 50 µL of a 1 wt% HA solution was cast on 
the bottom of the wells of a 96 well plate and then 50 µL of 0.017 M K3PA solution was added on 
top of the HA solution. Similarly, membranes containing the MMP sensitive and insensitive 
sequences were prepared using MMPsK3 and MMPiK3 PAs at 0.017 M concentration. The 
membranes were allowed to develop overnight and rinsed with sterile ultrapure water to ensure 
the removal of unreacted HA and PA.  
 
Enzymatic degradation of PA-HA membranes by exogenous enzymes (MMP-1 and 
hyaluronidase) 
Degradation studies were carried out by incubating the different PA-HA membranes in PBS at 37 
°C for 14 days without enzymes (control) or containing 10 nM of MMP-1 (human MMP-1, EC 
3.4.24.7, Sigma, USA) and 50 U.mL-1 of bovine testicular hyaluronidase (Type IV, EC 3.2.1.35, 
Sigma, USA) isolated or combined. The enzyme solutions were replaced every 72 h throughout the 
study and collected supernatants were stored at -20 °C for further analysis. At predetermined time 
points, the membranes were collected and their morphology examined by SEM, as described 
below. HA degradation on the membranes was assessed by quantification of N-acetylamino sugars 
in the collected supernatants using the fluorimetric Morgan–Elson assay method[49] and a 
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calibration curve of N-acetyl-D-glucosamine (NAG) standards. Three independent experiments 
were performed for each degradation condition and incubation time. 
 
Scanning electron microscopy (SEM) 
The microstructure of the membranes after degradation was analyzed by SEM. The membranes 
were first fixed in 2% glutaraldehyde/3% sucrose in PBS for 1 h at 4 °C followed by sequential 
dehydration in graded ethanol concentrations (from 20 to 100%). To remove ethanol, samples 
were dried in a critical point dryer (Tousimis Autosandri®-815 series A, USA). Prior observation, the 
samples were coated with a 15 nm thick layer of gold/palladium and imaged using an ultra-high 
resolution field emission gun scanning electron microscope (Nova™ NanoSEM 200) from FEI 
(Eindhoven, The Netherlands).  
 
Cell culture studies 
Isolation and culture of primary human dermal fibroblasts (hDFbs) 
hDFbs were isolated from skin samples discarded from abdominoplasty surgeries of consenting 
patients at Hospital da Prelada (Porto, Portugal). Briefly, the skin tissue was cut in pieces of 0.5 by 
0.5 cm and incubated in a dispase solution (2.4 U.mL-1 in PBS) at 4 °C overnight. After the tissue 
digestion, the epidermis was separated from the dermis, and the dermal pieces were digested 
overnight in a collagenase IA solution (125 U.mL-1 in PBS) at 4 °C. Digestion products containing 
hDFbs were poured through a 100 µm cell strainer and centrifuged at 200 g for 5 minutes. The 
pellet was resuspended and the fibroblasts were subsequently cultured in Dulbecco’s Modified 
Eagle Medium (DMEM) (Sigma, Germany) supplemented with 10% of fetal bovine serum (FBS, 
Gibco, UK) and 1% (v/v) antibiotic/antimycotic solution (A/B) (Gibco, UK) containing 100 units.mL-1 
penicillin and 100 mg.mL-1 streptomycin, in a 37 °C humidified atmosphere with 5% CO2. 
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Culture of hDFbs on the PA-HA membranes 
Membranes were prepared under sterile conditions as previously described. HA sterilization for 
cell studies was done by dissolving the polymer in water, filtering the solution through a 0.22 µm 
filter, followed by lyophilization in sterile falcon tubes (Sartorius, USA). PA solutions were sterilized 
by UV exposure for 15 minutes. Confluent hDFbs were harvested from monolayer cultures using 
TrypLE™ Express (Invitrogen, USA). Cells were seeded on the membranes (104 cells.cm-2) and 
cultured in DMEM supplemented with 10% FBS and 1% (v/v) A/B at 37 °C in a humidified 
atmosphere of 5% CO2 for 7 days. For inhibition studies, the cell culture media was supplemented 
with 20 µM of GM6001 MMP-1 inhibitor (Chemicon, USA). Cell culture media was replaced twice a 
week, and the collected conditioned media was stored frozen (-80 °C) until further analysis. At 
predetermined time points, cell-cultured membranes were collected to assess cell proliferation 
(DNA quantification), morphology and spreading (SEM, F-actin staining) and production of MMP-1, 
collagen and ECM proteins. Cell culture experiments were performed in triplicate for each 
condition and time point.  
 
Cell proliferation 
Cell proliferation was assessed at different culture times (1, 3 and 7 days) by quantifying the 
amount of double-stranded DNA (dsDNA). Quantification was performed using the Quant-iT™ 
PicoGreen® dsDNA Assay Kit (Invitrogen, Molecular Probes, Oregon, USA), according to the 
instructions of the manufacturer. Briefly, cells on the different membranes/coverslips were lysed 
by osmotic and thermal shock and the supernatant used for the DNA quantification. The 
fluorescent intensity of the dye was measured in a microplate reader (Synergie HT, Bio-Tek, USA) 
with excitation at 485/20 nm and emission at 528/20 nm. The DNA concentration for each sample 
was calculated using a standard curve (DNA concentration ranging from 0 to 1.5 mg/mL) relating 
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quantity of DNA and fluorescence intensity. Three samples were analyzed per condition and time 
point. 
 
Staining and confocal microscopy  
For examination of cell morphology and MMP-1 production at the protein level, fibroblasts 
cultured on the different membranes/coverslips were stained for F-actin and MMP-1. Cells were 
washed in PBS and subsequently fixed in 10% formalin solution (Sigma-Aldrich, Germany) for 30 
minutes at 4 °C. Cells were then washed once with 0.1 M glycine in PBS and twice with PBS and 
permeabilized with 2% BSA/ 0.2% Triton X-100 solution for 1 h at RT. Samples were incubated with 
primary antibody anti-MMP-1 (ab38929, 1:100, abcam, UK) for 1 h at RT and washed three times 
for 2 minutes with PBS. Samples were then incubated with the secondary antibody, anti-mouse 
Alexa 488 (1:200, Molecular Probes, Invitrogen, USA) and TRITC-conjugated phalloidin (1 U/mL, 
Sigma-Aldrich, Germany) for 1 h at RT. Cell nuclei were counterstained with 1 mg/mL DAPI 
(1:1000, Sigma-Aldrich, Germany) for 10 min and washed with PBS. Visualization was performed 
by confocal laser scanning microscopy (CLSM, Olympus FluoView 1000, Olympus, Japan). 
Background was subtracted and images were processed using FV10-ASW 3.1 software (Olympus, 
Japan). 
 
Expression of MMP-1 
MMP-1 expression by hDFbs was evaluated by analyzing the conditioned medium collected from 
fibroblast cultures on the PA-HA membranes, or peptide-coated glass coverslips, at different 
culture times (1, 3 and 7 days). MMP-1 was quantified with a double sandwich enzyme-linked 
Immunosorbent assay (ELISA) kit (Human Total MMP-1 DuoSet, R&D Systems, USA) according to 
the instructions of the manufacturer. Optical density (OD) was read at 450 nm and 570 nm in a 
microplate reader (Synergie HT, Bio-Tek, USA). The MMP-1 concentration for each sample was 
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calculated using a standard curve relating quantity of MMP-1 and OD. Three samples were 
analyzed per condition and time point. 
 
Quantification of collagen and total ECM proteins 
The deposition of ECM proteins by hDFbs cultured on the different membranes was analysed by 
quantification of collagen and other non-collagenous proteins using a colorimetric analysis (Sirius 
red/Fast green collagen staining kit, Chondrex, USA) and following the instructions of the 
manufacturer.[50] Briefly, cells were washed in PBS and subsequently fixed in 10% formalin solution 
(Sigma-Aldrich, Germany) for 30 minutes at 4 °C. Cells were washed again in PBS and immersed in 
200 µL of the dye solution containing Sirius red and fast green. The plates were incubated at RT for 
30 minutes in a rotary shaker. The dye solutions were then carefully withdrawn, and the plates 
were washed repeatedly with distilled water until the solution was colorless. After washing, 1 mL 
of dye extraction solution was added to each sample to elute the color. Optical density (OD) was 
read at 540 nm and 605 nm in a microplate reader (Synergie HT, Bio-Tek, USA). The values of 
collagen and total ECM proteins were calculated following the manufacturer instructions and 
normalized to DNA content. 
 
Data analysis and statistics 
All data values are presented as mean ± standard deviation (SD). Statistical analysis was performed 
using GraphPad Prism 5.00 software (San Diego, USA). Statistical differences between the different 
conditions (NAG, DNA, MMP-1 and collagenous/non-collagenous protein quantifications) were 
determined using a two-way analysis of variance (ANOVA) with a Bonferroni's multiple comparison 
post-hoc test (* p < 0.05, ** p < 0.01 and ***p < 0.001). 
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Figure 1. Design and characterization of the peptide amphiphiles (PAs) used in this study. (A) Chemical 
structure of the PAs showing the different functional segments. (B) Circular dichroism spectra of PA 
solutions (0.011 mM) at pH 3, 7, 9. (C) TEM images of PA nanostructures negatively stained with uranyl 
acetate (nanofibers were formed by the deposition of 0.1 wt% solutions in water followed by air drying on 
a carbon-coated TEM grid). 
 
Figure 2. Schematic illustration of the proposed enzyme-mediated degradation of self-assembled 
membranes made of hyaluronan (HA) and peptide nanofibers containing a cleavable site for MMP-1. The 
incorporation of a MMP-sensitive domain into the membrane design is expected to enhance their 
degradation by fibroblast secreted enzymes (HAase, MMP-1) and this would lead to enhance cellular 
invasion. 
 
Figure 3. Degradation profile of the self-assembled membranes containing different functionalities. (A) 
Quantification of N-acetylamino sugars released from the membranes when incubated in PBS and in PBS 
containing 50 U/mL HAase, 10 nM human MMP-1 or both enzymes; Control (K3-HA, A1), MMP sensitive 
(MMPsK3-HA, A2) and MMP insensitive (MMPiK3-HA, A3) (*p< 0.05, error bars represent standard deviation 
(n=3)). (B1) SEM images showing differences in membrane microstructure when exposed to enzyme 
solutions up to 14 days. (B2) Cross section of the MMPsK3-HA membranes after exposure to 10 nM MMP-1. 
 
Figure 4. Fibroblast proliferation when cultured on membranes with different functionalities. hDFb 
proliferation assessed by dsDNA quantification. (*p< 0.05, error bars represent standard deviation (n= 3)). 
 
Figure 5. Effect of membrane functionalization on the expression of MMP-1 by fibroblasts (hDFbs). (A) 
ELISA quantification of MMP-1 in cell culture supernatants (*p< 0.05, error bars represent standard 
deviation (n= 3)). (B) Confocal microscopy images of fibroblasts stained for MMP-1 (green), F-actin (red) 
and nuclei (blue) after 24 hours. 
 
Figure 6. Concentration of ECM proteins, collagenous (A) and non-collagenous (B), secreted by hDFbs when 
cultured on the membranes with different functionalities (*p< 0.05, error bars represent standard 
deviation (n= 3)). 
 
Figure 7. SEM micrographs showing differences in membrane microstructure after culturing hDFbs for 14 
days, suggesting membrane cell-mediated degradation. 
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Self-assembling membranes, molecularly 
designed with enzyme-cleavable building blocks 
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engineering applications. 
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